decisionhealth Newsletters, Coder Pink Sheets - 2023 Issue 3 (March)
Post-PHE prep: Fear of ‘telehealth cliff,’ drives opposition to DEA’s proposals for controlled prescriptions
Subscribe or sign in to view the full article.
Article Overview
This article covers proposed DEA telehealth rules released in March 2023 and the response from health care organizations, addiction medicine, psychiatry, and telehealth stakeholders. It explains the broad policy issues around in-person evaluation requirements, post-pandemic continuity of care, public comment opportunities, and related federal telemedicine oversight topics. The piece is relevant to clinicians, compliance teams, telehealth operators, behavioral health stakeholders, and anyone tracking controlled substance prescribing policy.
Why This Topic Matters
The proposed DEA rules could affect how telehealth-based care is delivered for controlled substances and buprenorphine-related treatment after the public health emergency. Readers working in telehealth, behavioral health, addiction medicine, or regulatory compliance need to understand the scope of the proposals and the public comment timeline.
Article Sections
-
DEA telehealth proposals and scope
Introduces the DEA’s March 2023 proposed rules and the categories of telehealth prescribing they address. Summarizes the general policy framework discussed in the article.
-
In-person requirements: Too much, too late?
Presents stakeholder reactions to the proposed in-person evaluation requirements and their possible effects on access to care. Discusses concerns raised by professional organizations and clinicians across affected specialties.
-
You still have time to comment
Explains the public comment period and encourages stakeholder participation in the rulemaking process. Also notes requests for clarification and broader policy concerns raised in responses.
-
Resources
Provides links and docket references for the DEA proposed rules discussed in the article.
What You Will Learn
- What the DEA proposed for telehealth-related prescribing after the PHE
- Which stakeholder groups are responding to the proposals
- Why some organizations say the proposals could affect access to care
- What opportunities exist for public comments on the rules
- How the article frames broader federal telemedicine policy issues
Who Should Read This
- Physicians
- Telehealth providers
- Behavioral health clinicians
- Addiction medicine professionals
- Compliance and regulatory staff
- Health system administrators
- Medical coders and billing staff monitoring policy changes
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com